東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies./
Author:	Liu, Yutong.
Description:	1 online resource (267 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 84-12, Section: A.
Contained By:	Dissertations Abstracts International84-12A.
Subject:	Bioengineering. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30422447click for full text (PQDT)
ISBN:	9798379616199

Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies.
Liu, Yutong.

Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies. - 1 online resource (267 pages)

Source: Dissertations Abstracts International, Volume: 84-12, Section: A.

Thesis (Ph.D.)--Harvard University, 2023.

Includes bibliographical references

Adoptive T cell therapy (ACT), including chimeric antigen receptor (CAR) T cell therapy, is a type of immunotherapy that typically uses a patient's own T cells to treat tumors. While ACT has demonstrated tremendous success in hematological malignancies, its efficacy in solid tumors remains limited. Current approaches to improving ACT efficacy focus on developing new CAR vectors that give T cells more advanced properties. However, research and clinical trial data have revealed that the phenotype of the T cell product could also significantly affect its efficacy. This thesis explores two ways to control the phenotypes of T cells to achieve better efficacy against tumors.In the first part, T cells were metabolically labeled with unnatural sugar nanoparticles. Subsequent cytokine conjugation onto T cells allowed them to preferentially differentiate into a type 1 immune response. This method also addressed the obstacle of antigen escape in ACT treatment by activating host immunity and inducing antigen spreading, resulting in a significantly prolonged lifespan in solid tumor models and complete response with only half of the usual curative dose in liquid tumor models.In the second part, the effects of mechanical properties of the extracellular matrix (ECM) on T cells were studied, and its potential applications in ACT product manufacturing were explored. A model ECM based on collagen type I was developed to allow for independent control of matrix stiffness and viscoelasticity, and was subsequently used to generate phenotypically and functionally distinct T cells. T cells harvested from more elastic matrices demonstrated a more effector-like phenotype and better efficacy against tumors in vivo.These two approaches shed light on methods to improve and optimize T cell product manufacturing by controlling the phenotype of the final T cell product.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798379616199Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

CancerIndex Terms--Genre/Form:

542853
Electronic books.

Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies.
LDR:03206nmm a2200397K 4500 001 2362999
005 20231109104728.5
006 m o d
007 cr mn ---uuuuu
008 241011s2023 xx obm 000 0 eng d
020 $a 9798379616199
035 $a (MiAaPQ)AAI30422447
035 $a AAI30422447
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Liu, Yutong. $3 3703742
245 1 0 $a Optimizing the Efficacy of Adoptive T Cell Transfers and CAR-T Therapies.
264 0 $c 2023
300 $a 1 online resource (267 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 84-12, Section: A.
500 $a Advisor: Mooney, David.
502 $a Thesis (Ph.D.)--Harvard University, 2023.
504 $a Includes bibliographical references
520 $a Adoptive T cell therapy (ACT), including chimeric antigen receptor (CAR) T cell therapy, is a type of immunotherapy that typically uses a patient's own T cells to treat tumors. While ACT has demonstrated tremendous success in hematological malignancies, its efficacy in solid tumors remains limited. Current approaches to improving ACT efficacy focus on developing new CAR vectors that give T cells more advanced properties. However, research and clinical trial data have revealed that the phenotype of the T cell product could also significantly affect its efficacy. This thesis explores two ways to control the phenotypes of T cells to achieve better efficacy against tumors.In the first part, T cells were metabolically labeled with unnatural sugar nanoparticles. Subsequent cytokine conjugation onto T cells allowed them to preferentially differentiate into a type 1 immune response. This method also addressed the obstacle of antigen escape in ACT treatment by activating host immunity and inducing antigen spreading, resulting in a significantly prolonged lifespan in solid tumor models and complete response with only half of the usual curative dose in liquid tumor models.In the second part, the effects of mechanical properties of the extracellular matrix (ECM) on T cells were studied, and its potential applications in ACT product manufacturing were explored. A model ECM based on collagen type I was developed to allow for independent control of matrix stiffness and viscoelasticity, and was subsequently used to generate phenotypically and functionally distinct T cells. T cells harvested from more elastic matrices demonstrated a more effector-like phenotype and better efficacy against tumors in vivo.These two approaches shed light on methods to improve and optimize T cell product manufacturing by controlling the phenotype of the final T cell product.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Bioengineering. $3 657580
650 4 $a Cellular biology. $3 3172791
650 4 $a Therapy. $3 3343697
653 $a Cancer
653 $a Cell therapy
653 $a Immunotherapy
653 $a Mechanobiology
653 $a T cell
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0202
690 $a 0379
690 $a 0212
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Harvard University. $b Engineering and Applied Sciences - Engineering Sciences. $3 3184097
773 0 $t Dissertations Abstracts International $g 84-12A.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30422447 $z click for full text (PQDT)